WASHINGTON, D.C. – AdvaMed today announced the launch of the first-ever AdvaMed-owned and -produced podcast: MedTech POV. The podcast is hosted by AdvaMed President and CEO Scott Whitaker and covers the intersection of medtech and policy from every perspective.
Top News
Blog Post | April 15, 2021
Medical device manufacturers are increasingly targeted by a mass tort generation machine of unprecedented size and scope. A too hidden network of financiers and claim generators fund TV, radio, internet, and social media ads to recruit large numbers of potential plaintiffs.
Blog Post | April 14, 2021
The medical technology community is made up of scientists, manufacturers, researchers, and engineers. Dr. Ajit Yoganathan is a unique combination of them all. Even so, Dr. Yoganathan – or Dr. Y to his colleagues and friends – would describe himself using an entirely different, but apt moniker: A conductor.
Events
April
22
April 22, 2021 | Online
Please join FDA and AdvaMed on Thursday, April 22 for a virtual Educational Meeting from 9:00 a.m. to 1:00 p.m. ET. The agenda includes important updates by FDA’s Office of Health Technology 6 (OHT6... Read More
April
27
April 27, 2021 | Online
Please note: At this time, we have reached capacity for The Value Assessment Workshop. We are looking into hosting a second event in the fall. Please click here to sign up for updates.
The Value... Read More
May
06
May 6, 2021 |
The Digital MedTech Conference gathers the digital health community for an exploration of the evolving digital medtech landscape and the trends impacting the industry.
May
10
May 10, 2021 to May 12, 2021 | Online
Please join us virtually from May 10-12, 2021 for the 13th Annual FDA/AdvaMed Medical Device Statistics Issues Conference. This annual conference brings together leading authorities from FDA,... Read More
May
19
May 19, 2021 | Online
Throughout the COVID-19 pandemic, a unique type of leadership has been critical towards effectively navigating and responding to this extraordinary challenge. Leading during an uncertain, ever-... Read More
Featured Video
We thank our member companies for their continued efforts to mobilize for health care workers on the frontlines. Learn more about how the industry has come together in the fight against COVID-19.
Industry News
San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served organizations. This step enables organizations to provide DDTD’s high performance COVID-19 serology tests along with automatic digitized reads that are transmitted simultaneously and...
SALT LAKE CITY--(BUSINESS WIRE)--O2TODAY ("O2TODAY"), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramics, announced today they have entered into a worldwide exclusive licensing agreement.
O2TODAY expects to release their first consumer mask integrated with SINTX’s silicon nitride...
BOSTON, Jan. 20, 2021 -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., ("Cardiva") an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an...
Washington, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Today, the U.S. Small Business Administration announced 38 companies, seven organizations and 14 individuals as the winners of the prestigious Tibbetts Award for their accomplishments in creating cutting-edge technologies. The Tibbetts Awards, named after Roland Tibbetts, the founder of the SBIR Program, honors these awardees for the exceptional successes they achieved through SBA’s Small Business Innovation Research (SBIR) and Small Business...
Ortho’s VITROS® SARS-CoV-2 Antigen Test is the first high-volume COVID-19 antigen test to receive Food and Drug Administration (FDA) Emergency Use Authorization (EUA).
With utility for mass-scale testing and same-day results for labs, Ortho’s latest COVID-19 solution can run up to 130 tests per hour.
The test is run on Ortho’s high-volume VITROS® Systems, which are installed in over 5,600 laboratories around the world with 1,500 installed in the U.S.
RARITAN, N.J. (January 12, 2021) – Ortho...
Twitter Feed
April 19, 2021 - 12:51pm
Mass tort generation machines put litigation awards above patient safety. AdvaMed’s Pat Fogarty explains. https://t.co/m8V1ofyBPb
April 19, 2021 - 12:41pm
A recent survey conducted by @ASTRO_org suggests that 66% of doctors reported more advanced-stage cancer diagnoses… https://t.co/zUJrsTZPPF




